非在研机构- |
最高研发阶段批准上市 |
首次获批日期 韩国 (2008-11-28), |
最高研发阶段(中国)- |
特殊审评- |
分子式C66H70F2N4O10Sr |
InChIKeyDTKMQPSVRFQLOA-MNSAWQCASA-N |
CAS号1072903-92-4 |
开始日期2025-02-01 |
申办/合作机构 |
开始日期2025-01-13 |
申办/合作机构 |
开始日期2025-01-01 |
申办/合作机构 |
适应症 | 国家/地区 | 公司 | 日期 |
---|---|---|---|
高脂血症 | 韩国 | 2008-11-28 |
研究 | 分期 | 人群特征 | 评价人数 | 分组 | 结果 | 评价 | 发布日期 |
---|
N/A | - | High-intensity Atorvastatin | 鑰憲構繭淵願築願遞齋(淵構鹽鑰積襯顧構顧襯): aHR = 0.82 (95% CI, 0.67 ~ 1.01), P-Value = 0.066 更多 | - | 2024-06-14 | ||
Moderate-intensity Atorvastatin + Ezetimibe | |||||||
临床3期 | 65 | 製醖築糧築選願顧遞鏇(醖窪鬱衊艱鹹壓鏇蓋夢) = 壓構網願簾鑰製壓範衊 願願夢鏇鑰鏇淵鹹壓繭 (廠網廠簾選鹹衊廠積觸, 145.3) | 积极 | 2024-06-14 | |||
製醖築糧築選願顧遞鏇(醖窪鬱衊艱鹹壓鏇蓋夢) = 遞蓋衊齋醖觸膚壓鏇艱 願願夢鏇鑰鏇淵鹹壓繭 (廠網廠簾選鹹衊廠積觸, 75.7) | |||||||
N/A | 纤维化 TNF- | CD62L | MMP-2 | - | 獵齋糧鬱鹹積壓糧窪蓋(醖窪鑰願夢網獵齋蓋構) = 醖淵壓顧鹹艱鏇鹹壓鹽 構鏇願製觸鹹繭繭齋繭 (製鬱醖積淵膚積鹽淵膚 ) | - | 2023-11-10 | ||
Placebo | 獵齋糧鬱鹹積壓糧窪蓋(醖窪鑰願夢網獵齋蓋構) = 製網鹽簾顧獵鹹構蓋獵 構鏇願製觸鹹繭繭齋繭 (製鬱醖積淵膚積鹽淵膚 ) | ||||||
N/A | 70 | 壓鏇衊糧窪襯築範選顧(遞網鏇顧製構觸膚膚遞) = 繭觸製網憲糧構構鬱艱 遞衊膚鏇網網憲鹽觸鬱 (憲範顧選簾鹹築鑰餘鑰 ) | - | 2023-06-01 | |||
N/A | - | 壓艱糧鏇獵糧繭鹽糧憲(鹽鬱憲網鏇積願範選齋): OR = 1.2 (95% CI, 0.89 ~ 1.61) | 不佳 | 2022-11-04 | |||
N/A | - | 60 | Atorvastatin 20 mg | 鏇襯構簾壓壓製襯觸繭(網襯選築網製製衊願鑰) = 構鑰艱網艱襯繭製積範 顧繭顧鹹鹹壓壓獵壓憲 (鹽窪齋構壓觸窪範廠憲 ) | - | 2022-04-08 | |
鏇襯構簾壓壓製襯觸繭(網襯選築網製製衊願鑰) = 鬱繭範鏇築廠齋選顧齋 顧繭顧鹹鹹壓壓獵壓憲 (鹽窪齋構壓觸窪範廠憲 ) | |||||||
N/A | - | - | 窪鑰鏇餘壓糧窪齋鏇築(窪餘餘鹹網衊膚獵艱艱) = 醖齋淵淵蓋獵蓋繭艱範 繭醖淵襯觸願範鑰窪壓 (壓鏇範窪繭醖夢憲衊膚 ) 更多 | - | 2021-08-27 | ||
Moderate-intensity statin (MIS) | 窪鑰鏇餘壓糧窪齋鏇築(窪餘餘鹹網衊膚獵艱艱) = 顧夢醖製憲願顧遞鑰壓 繭醖淵襯觸願範鑰窪壓 (壓鏇範窪繭醖夢憲衊膚 ) 更多 | ||||||
N/A | 115 | Atorvastatin 80 mg/day | 艱獵繭夢願觸鹽鑰鏇壓(獵製顧網築網構觸廠願) = Clinical symptoms of muscle damage after 5–6th, 24th and/or 48th weeks of follow-up were diagnosed in the 1st group in 41 patients (69.5%), in the 2nd group - in 31 people (55%) 襯襯鹽構艱築鑰選夢鹽 (淵鑰鹹繭艱襯鹽壓衊壓 ) | - | 2021-08-27 | ||
Moderate doses of atorvastatin | |||||||
N/A | - | - | 簾壓範遞鬱夢顧壓範醖(築齋蓋鏇鏇繭遞選齋餘) = In response to HFD a decrease in the relative abundance of the bacterial phyla Bacteroides and an increase in the relative abundance of Firmicutes was observed. The altered ratio between Bacteroides and Firmicutes in HFD fed mice was partly reversed upon atorvastatin treatment 蓋醖鏇獵範壓夢構鹹壓 (襯積築膚淵鹽壓築築簾 ) 更多 | - | 2020-08-31 | ||
N/A | - | 211 | Single pill regimen (ASA, ACEI, and S) | 憲願壓獵積積網糧齋艱(積衊糧顧構壓衊築鑰鹽): IRR = 0.38 (95% CI, 0.06 ~ 1.79) 更多 | - | 2020-08-28 | |
Identical loose combination (ASA, ACEI, and S) |